Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Pediazync - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Pediazync

Approved

STANDARD

Pediazync

New Myrex Laboratories, Inc.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: bd5cf12aca3db6c2
Company: New Myrex Laboratories, Inc.
Type: Standard

Approval Details

Approval Id: bd5cf12aca3db6c2
Drug Approval Philippines Name: Pediazync
Product Name: Pediazync
Registration Number: DRP-3128-03
Brand Name: Pediazync
Generic Name: Ascorbic Acid + Zinc
Dosage Form: Syrup (Mango flavor)
Dosage Strength: 100mg/10mg per 5mL
Manufacturer: New Myrex Laboratories, Inc.
Distributor: Reta Drug
Issuance Date: 28 December 2021
Expiry Date: 15 July 2026
Classification: Over-The-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

bd5cf12aca3db6c2

Type

Standard

Back to Philippines FDA Approvals